ASCIA, the Australasian Society of Clinical Immunology and Allergy, is working together with patient organisations and other collaborators to develop a National Immunodeficiency Strategy, for both Australia and New Zealand.
The National Immunodeficiency Strategy’s Mission is to improve the health and wellbeing of people with PIDs (primary immunodeficiencies) and minimise the burden on individuals, carers, health services and community.
On Friday 8 March 2019, ASCIA, hosted the first meeting for the National Immunodeficiency Strategy at the Parkroyal Hotel Melbourne Airport. This meeting involved a total of 32 representatives from:
- ASCIA (Clinical immunology specialists, nurses and dietitians)
- Patient organisations (AusPIPS, Immune Deficiencies Foundation of Australia, Immune Deficiencies Foundation of New Zealand, HAE Australasia)
- Major PID research centres (Jeffrey Modell Foundation, Australian National University, Walter and Eliza Hall, Garvan Institute)
- Funding bodies (National Blood Authority, Jurisdictional Blood Committee)
- Supply channels (Australian Red Cross Blood Service)
- Other collaborators (NPS MedicineWise)
The National Immunodeficiency Strategy meeting coincided with International Women's Day. ASCIA was proud to have three past Presidents (Prof Connie Katelaris, Prof Jo Douglass, Dr Melanie Wong) and the current President Elect (Prof Michaela Lucas), providing leadership and working together at this meeting.
Unrestricted educational grants from CSL Behring and Grifols assisted ASCIA to host this meeting. The program and outcomes from this meeting are not influenced by this support.
Content created March 2019